← Back to Clinical Trials
Recruiting NCT06884761

NCT06884761 Routine Activity and Preterm Delivery Risk in Women With a Short Cervix

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06884761
Status Recruiting
Phase
Sponsor Wolfson Medical Center
Condition Cervical Shortening
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2025-01-15
Primary Completion 2027-12-29

Trial Parameters

Condition Cervical Shortening
Sponsor Wolfson Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex FEMALE
Min Age N/A
Max Age N/A
Start Date 2025-01-15
Completion 2027-12-29
Interventions
Maximal Rest

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to evaluate the effect of routine activity versus rest on the risk of preterm delivery in pregnant women with a short cervix diagnosed between 24 and 34 weeks of gestation. The main questions it aims to answer are: Does routine activity influence the gestational age at delivery? How does routine activity affect secondary outcomes such as preterm labor, premature rupture of membranes, delivery mode, maternal anxiety, and satisfaction? Researchers will compare women instructed to maintain routine activity (control group) to women advised to practice maximal rest (intervention group) to see if physical activity impacts preterm birth outcomes. Participants will: Wear a smart band to monitor step counts over a two-week period. Be randomized into two groups: one encouraged to maintain routine activity and the other advised to follow strict rest protocols. Undergo regular follow-ups at a high-risk pregnancy clinic and have their data collected through hospital records and smart band tracking. This randomized controlled trial will assess gestational age at delivery as the primary outcome, along with secondary maternal and neonatal outcomes, providing insight into the role of physical activity in managing pregnancies complicated by a short cervix.

Eligibility Criteria

Inclusion Criteria: * Singleton pregnancies between 24+0 and 34+6 weeks. * Short cervical length (\<25 mm) confirmed via transvaginal ultrasound. * No medical contraindications to physical activity. Exclusion Criteria: * Twin pregnancies or higher-order multiples. * Medical indications for reduced mobility (e.g., symphysiolysis, fall risk). * Maternal comorbidities, fetal distress, vaginal bleeding, PPROM, or need for immediate delivery.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology